Rectus Femoris Characteristics in Post Stroke Spasticity: Clinical Implications from Ultrasonographic Evaluation
In stroke survivors, rectus femoris (RF) spasticity is often implicated in gait pattern alterations such as stiff knee gait (SKG). Botulinum toxin type A (BoNT-A) is considered the gold standard for focal spasticity treatment. However—even if the accuracy of injection is crucial for BoNT-A efficacy—...
Main Authors: | Lucia Cosenza, Alessandro Picelli, Danila Azzolina, Marco Alessandro Minetto, Marco Invernizzi, Michele Bertoni, Andrea Santamato, Alessio Baricich |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Toxins |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6651/12/8/490 |
Similar Items
-
Triceps Surae Muscle Characteristics in Spastic Hemiparetic Stroke Survivors Treated with Botulinum Toxin Type A: Clinical Implications from Ultrasonographic Evaluation
by: Marco Battaglia, et al.
Published: (2021-12-01) -
BoNT-A for Post-Stroke Spasticity: Guidance on Unmet Clinical Needs from a Delphi Panel Approach
by: Alessio Baricich, et al.
Published: (2021-03-01) -
Reasons and Determinants of BoNT-A Treatment Discontinuation in Patients Living with Spasticity: A 10-Year Retrospective Analysis
by: Nicoletta Cinone, et al.
Published: (2022-09-01) -
The Lack of Systemic and Subclinical Side Effects of Botulinum Neurotoxin Type-A in Patients Affected by Post-Stroke Spasticity: A Longitudinal Cohort Study
by: Marco Battaglia, et al.
Published: (2022-08-01) -
Early Botulinum Toxin Type A Injection for Post-Stroke Spasticity: A Longitudinal Cohort Study
by: Alessandro Picelli, et al.
Published: (2021-05-01)